Search Results - "BONIFAZI, F"

The natural history and epidemiology of insect venom allergy: clinical implications by Bilò, M. B., Bonifazi, F.

“…Summary Hymenoptera stings can cause severe systemic allergic reactions and occasionally fatal anaphylaxis, which contribute significantly to morbidity and…”
Get full text

Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice by Bonifazi, F., Jutel, M., Biló, B. M., Birnbaum, J., Muller, U.

“…Based on the knowledge of the living conditions and habitat of social Aculeatae a series of recommendations have been formulated which can potentially greatly…”
Get full text

Diagnosis of Hymenoptera venom allergy by Biló, B. M., Rueff, F., Mosbech, H., Bonifazi, F., Oude‐Elberink, J. N. G.

“…The purpose of diagnostic procedure is to classify a sting reaction by history, identify the underlying pathogenetic mechanism, and identify the offending…”
Get full text

Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation by Genadieva-Stavrik, S., Boumendil, A., Dreger, P., Peggs, K., Briones, J., Corradini, P., Bacigalupo, A., Socié, G., Bonifazi, F., Finel, H., Velardi, A., Potter, M., Bruno, B., Castagna, L., Malladi, R., Russell, N., Sureda, A.

“…This registry-based analysis highlights the significant reduction of non-relapse mortality associated to myeloablative allogeneic stem cell transplantation for…”
Get full text

Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect by Dodero, A, Spina, F, Narni, F, Patriarca, F, Cavattoni, I, Benedetti, F, Ciceri, F, Baronciani, D, Scimè, R, Pogliani, E, Rambaldi, A, Bonifazi, F, Dalto, S, Bruno, B, Corradini, P

“…Rescue chemotherapy or autologous stem cell transplantation (autoSCT) gives disappointing results in relapsed peripheral T-cell lymphomas (PTCLs). We have…”
Get full text

Ocular surface analysis in hematological patients before and after allogeneic hematopoietic stem cell transplantation: implication for daily clinical practice by Giannaccare, G, Bonifazi, F, Sessa, M, Dan, E, Arpinati, M, Fresina, M, Bandini, G, Cavo, M, Versura, P, Campos, E C

“…Purpose To evaluate ocular surface parameters before and after hematopoietic stem cell transplantation (HSCT) and to correlate them with clinical and…”
Get full text

Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT by Cahu, X, Labopin, M, Giebel, S, Aljurf, M, Kyrcz-Krzemien, S, Socié, G, Eder, M, Bonifazi, F, Bunjes, D, Vigouroux, S, Michallet, M, Stelljes, M, Zuckerman, T, Finke, J, Passweg, J, Yakoub-Agha, I, Niederwieser, D, Sucak, G, Sengeløv, H, Polge, E, Nagler, A, Esteve, J, Mohty, M

“…Allogeneic hematopoietic stem cell transplantation (allo-SCT) is a therapeutic option for adult patients with T-cell ALL (T-ALL). Meanwhile, few allo-SCT data…”
Get full text

Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party by Sobh, M, Michallet, M, Gahrton, G, Iacobelli, S, van Biezen, A, Schönland, S, Petersen, E, Schaap, N, Bonifazi, F, Volin, L, Meijer, E, Niederwieser, D, El-Cheikh, J, Tabrizi, R, Fegeux, N, Finke, J, Bunjes, D, Cornelissen, J, Einsele, H, Bruno, B, Potter, M, Fanin, R, Mohty, M, Garderet, L, Kröger, N

“…We describe the use and outcomes of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for multiple myeloma (MM) in Europe between January 1990 and…”
Get full text

Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission by Saraceni, F, Bruno, B, Lemoli, R M, Meloni, G, Arcese, W, Falda, M, Ciceri, F, Alessandrino, E P, Specchia, G, Scimè, R, Raimondi, R, Bacigalupo, A, Bosi, A, Onida, F, Rambaldi, A, Bonifazi, F, Olivieri, A

Get full text

Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System by Della Porta, M G, Jackson, C H, Alessandrino, E P, Rossi, M, Bacigalupo, A, van Lint, M T, Bernardi, M, Allione, B, Bosi, A, Guidi, S, Santini, V, Malcovati, L, Ubezio, M, Milanesi, C, Todisco, E, Voso, M T, Musto, P, Onida, F, Iori, A P, Cerretti, R, Grillo, G, Molteni, A, Pioltelli, P, Borin, L, Angelucci, E, Oldani, E, Sica, S, Pascutto, C, Ferretti, V, Santoro, A, Bonifazi, F, Cazzola, M, Rambaldi, A

“…Allogeneic hematopoietic stem cell transplantation (allo-SCT) represents the only curative treatment for patients with myelodysplastic syndrome (MDS), but…”
Get full text

Availability of HLA-allele-matched unrelated donors and registry size: Estimation from haplotype frequency in the Italian population by Sacchi, N., Ciceri, F., Bonifazi, F., Algeri, M., Gallina, A., Pollichieni, S., Raggio, E., Hadj-Amar, B., Lombardini, L., Pupella, S., Liumbruno, G., Cardillo, M.

“…In Italy, an HLA-matched unrelated donor is currently the primary donor when a HLA matched sibling is not found for allogeneic haematopoietic stem cell…”
Get full text

The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergy by Passalacqua, G., Melioli, G., Bonifazi, F., Bonini, S., Maggi, E., Senna, G., Triggiani, M., Nettis, E., Rossi, R. E., Vacca, A., Canonica, G. W.

“…Background The IgE response is directed against specific components from an allergenic source. The traditional diagnostic methods use whole extracts,…”
Get full text

Long‐term outcome of patients receiving haematopoietic allogeneic stem cell transplantation as first transplant for high‐risk Hodgkin lymphoma: a retrospective analysis from the Lymphoma Working Party‐EBMT by Gutiérrez‐García, G., Martínez, C., Boumendil, A., Finel, H., Malladi, R., Afanasyev, B., Tsoulkani, A., Wilson, K. M. O., Bloor, A., Nikoloudis, M., Richardson, D., López‐Corral, L., Castagna, L., Cornelissen, J., Giltat, A., Collin, M., Fanin, R., Bonifazi, F., Robinson, S., Montoto, S., Peggs, K. S., Sureda, A.

“…Summary We analysed long‐term outcome of patients receiving haematopoietic allogeneic stem cell transplantation (allo‐HSCT) as a first transplant for high‐risk…”
Get full text

Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria) by Olivieri, A., Mancini, G., Olivieri, J., Marinelli Busilacchi, E., Cimminiello, M., Pascale, S. P., Nuccorini, R., Patriarca, F., Corradini, P., Bacigalupo, A., Angelini, S., Poloni, A., Grillo, G., Onida, F., Martino, M., Di Renzo, N., Nagler, A., Mordini, N., Bruno, B., Ciceri, F., Bonifazi, F.

“…We conducted a phase I–II study to evaluate Nilotinib (NIL) safety and pharmacokinetics in 22 SR-cGVHD patients; we also evaluated ORR by using in parallel NIH…”
Get full text

Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome by CORRADINI, P, DODERO, A, POGLIANI, E, LOCASCIULLI, A, MILANI, R, CARNITI, C, BACIGALUPO, A, RAMBALDI, A, BONIFAZI, F, OLIVIERI, A, GIANNI, A. M, TARELLA, C, FARINA, L, FANIN, R, PATRIARCA, F, MICELI, R, MATTEUCCI, P, BREGNI, M, SCIME, R, NARNI, F

“…The safety and efficacy of reduced-intensity conditioning (RIC) followed by allogeneic stem cell transplantation (SCT) for relapsed lymphomas remains…”
Get full text

Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO) by Todisco, E, Ciceri, F, Boschini, C, Giglio, F, Bacigalupo, A, Patriarca, F, Donnini, I, Alessandrino, E P, Arcese, W, Iori, A P, Marenco, P, Cavattoni, I, Chiusolo, P, Terruzzi, E, Castagna, L, Santoro, A, Bosi, A, Oldani, E, Bruno, B, Bonifazi, F, Rambaldi, A

“…The clinical outcome of primary refractory (PRF) AML patients is poor and only a minor proportion of patients is rescued by allogenic hematopoietic stem cell…”
Get full text

Asthma severity and medical resource utilisation by Antonicelli, L, Bucca, C, Neri, M, De Benedetto, F, Sabbatani, P, Bonifazi, F, Eichler, H-G, Zhang, Q, Yin, D.D

“…Asthma represents a growing public health problem and the cost of asthma has been rising in many countries. The aim of this study was to estimate the direct…”
Get full text

Treatment of refractory chronic GVHD with rituximab: a GITMO study by ZAJA, F, BACIGALUPO, A, LASZLO, D, ALESSANDRINO, P. E, NARNI, F, SICA, S, OLIVIERI, A, SPEROTTO, A, BOSI, A, BONIFAZI, F, FANIN, R, PATRIARCA, F, STANZANI, M, VAN LINT, M. T, FILI, C, SCIME, R, MILONE, G, FALDA, M, VENER, C

“…The anti-CD20 chimaeric monoclonal antibody Rituximab has recently been shown to induce significant clinical response in a proportion of patients with…”
Get full text

Predicting ICANS by means of plasma CAR‐T cell derived extracellular vesicles in patients undergoing infusion of anti‐CD19 CAR‐T cells by Felice, F., Storci, G., Ricci, F., Tazzari, P. L., Matteis, S., Bertuccio, S. N., Rossini, L., Tomassini, E., Dicataldo, M., Laprovitera, N., Barbato, F., Ursi, M., Messelodi, D., Cortelli, P., Guarino, M., Maffini, E., Roberto, M., Dan, E., Sinigaglia, B., Santi, S., Ferracin, M., Pellegrini, C., Stefoni, V., Guadagnuolo, S., Casadei, B., Zinzani, P. L., Bonafe, M., Bonifazi, F.

Get full text

The Italian CART‐SIE real life multicenter observational study on Chimeric Antigen Receptor T‐cell (CAR‐T) therapy for large B‐cell (LBCL) and mantle cell (MCL) lymphomas by Chiappella, A., Dodero, A., Ljevar, S., Pennisi, M., Bonifazi, F., Philippis, C., Galli, E., Di Rocco, A., Tisi, M. C., Cutini, I., Carrabba, M. G., Musso, M., Martino, M., Barbui, A. M., Botto, B., Farina, M., Grillo, G., Patriarca, F., Ladetto, M., Arcaini, L., Bermema, A., Miceli, R., Magni, M., Zinzani, P. L., Bramanti, S., Chiusolo, P., Martelli, M., Carniti, C., Corradini, P.

Get full text